Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.4M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
23M
-
Shares change
-
+633
-
Total reported value, excl. options
-
$600M
-
Value change
-
+$12.3K
-
Number of buys
-
58
-
Number of sells
-
-20
-
Price
-
$26.14
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2014
91 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q2 2014.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23M shares
of 80.4M outstanding shares and own 28.55% of the company stock.
Largest 10 shareholders include FMR LLC (4.51M shares), BROOKSIDE CAPITAL MANAGEMENT LLC (2.86M shares), CREDIT SUISSE AG/ (2.27M shares), Sectoral Asset Management Inc (1.55M shares), WELLINGTON MANAGEMENT CO LLP (1.51M shares), BlackRock Fund Advisors (904K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (880K shares), State Street Corp (846K shares), WESTFIELD CAPITAL MANAGEMENT CO LP (729K shares), and PERCEPTIVE ADVISORS LLC (672K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.